molecules of the month

Merck IDO1 inhibitor

heme-displacing IDO1 inhibitor

human predicted QD dose of 26 mg

from 260k MS-based screen and SBDD

ACS Med. Chem. Lett. Mar. 10, 2020

Merck, Boston, MA

Merck IDO1 inhibitor
1 min read

Merck IDO1 inhibitor (Merck heme-displacing oral IDO1 inhibitor)

request a trial

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.

already a member? log in: